By Shania Kennedy
December 06, 2023 – A systematic review and meta-analysis of randomized clinical trials (RCTs) published last week in eClinicalMedicine showed that artificial intelligence (AI)-aided colonoscopy may enhance the detection of colorectal neoplasia.
The work…
By Anuja Vaidya
December 04, 2023 – While mHealth application-based interventions are effective in treating moderate and severe depression, certain factors impact their efficacy, like in-app notifications and the length of treatment delivery, recent research shows.
Published…
Continue Reading
What You Should Know:
– QuantHealth, an AI-powered clinical trial design startup, today announced a major product upgrade to its platform with the launch of Katina, a new tool that utilizes AI to simulate clinical…
Continue Reading
In a world where health research and clinical trials are crucial for advancing medical innovations, the process of recruitment has traditionally been fraught with challenges. However, the landscape is changing with the advent of…
Continue Reading
ConcertAI’s TeraRecon unveils pioneering AI advancements at RSNA23, bolstering clinical research and patient care. Their multi-modal AI platform, in collaboration with MSKCC, aims to revolutionize oncology research. Jeff Elton emphasizes the significance of multi-modal…
Continue Reading
Randomized clinical trials (RCT) represent the cornerstone of evidence-based medicine but are resource-intensive. We propose and evaluate a machine learning (ML) strategy of adaptive predictive enrichment through computational trial phenomaps to optimize RCT enrollment….
Continue Reading
Pharmaceutical giant AstraZeneca announced the launch of Evinova, a health technology business focused on bringing digital health solutions already in use globally by the pharma company to clinical research organizations (CROs), trial sponsors and…
Continue Reading
What You Should Know:
– AstraZeneca, a global biopharmaceutical company, has announced the launch of Evinova, a new business venture dedicated to providing cutting-edge digital health solutions that address the evolving needs of healthcare professionals,…
Continue Reading
Cleerly, a leading innovator in the field of cardiovascular disease diagnosis, today announced the launch of the TRANSFORM trial at the American Heart Association’s (AHA) 2023 Scientific Sessions. This groundbreaking trial aims to revolutionize…
Continue Reading
Background: The rapid growth of digital health apps has necessitated new regulatory approaches to ensure compliance with safety and effectiveness standards. Nonadherence and heterogeneous user engagement with digital health apps can lead to trial…
Continue Reading
